Chandak Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 2.89 M
as on 17-11-2024
- Company Age 39 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.59 M
as on 17-11-2024
- Revenue 25.96%
(FY 2023)
- Profit 55.79%
(FY 2023)
- Ebitda 55.63%
(FY 2023)
- Net Worth 57.24%
(FY 2023)
- Total Assets 18.99%
(FY 2023)
About Chandak Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.89 M.
The company currently has active open charges totaling ₹4.59 M.
Ashok Chandak and Rajender Chandak serve as directors at the Company.
- CIN/LLPIN
U24230TG1985PTC005415
- Company No.
005415
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Chandak Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Chandak  | Director | 28-Mar-1985 | Current |
| Rajender Chandak | Director | 28-Mar-1985 | Current |
Financial Performance of Chandak Laboratories.
Chandak Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.96% increase. The company also saw a substantial improvement in profitability, with a 55.79% increase in profit. The company's net worth Soared by an impressive increase of 57.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chandak Laboratories?
In 2023, Chandak Laboratories had a promoter holding of 99.90% and a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Enco Speciality Chemicals Private LimitedActive 2 years 11 months
Rajender Chandak is a mutual person
- Bharath Advanced Therapeutics Private LimitedActive 11 months 5 days
Rajender Chandak is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Hyderabad Creation Date: 06 Jun 1990 | ₹0.50 M | Open |
State Bank Of Hyderabad Creation Date: 24 Jul 1989 | ₹0.80 M | Open |
Andhra Pradesh State Financial Corporation Creation Date: 16 Oct 1986 | ₹3.29 M | Open |
How Many Employees Work at Chandak Laboratories?
Chandak Laboratories has a workforce of 25 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chandak Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chandak Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
